» Articles » PMID: 12867410

Childhood Ocular Myasthenia Gravis

Overview
Journal Ophthalmology
Publisher Elsevier
Specialty Ophthalmology
Date 2003 Jul 18
PMID 12867410
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: To investigate the clinical manifestations and ocular findings in children with ocular myasthenia gravis (MG) that rarely have been reported in the literature.

Design: Retrospective, noncomparative case series.

Participants: Twenty-four consecutive patients less than 15 years of age with ocular MG treated between June 1988 and July 2001.

Methods: The medical records of 6 boys and 18 girls with ocular MG were reviewed retrospectively.

Main Outcome Measures: Alternate prism cover and uncover test, examination of ductions and versions, and visual acuity.

Results: Mean age at onset was 38 months. Ptosis was found in 23 patients (96%), strabismus in 21 patients (88%), and amblyopia in 5 patients (21%). Exotropia combined with vertical heterotropia was the most frequent type of strabismus. Ductions were limited in 17 patients (71%), among whom supraduction or infraduction limitations were most frequently observed. Contrary to previous reports, medial rectus underaction was less common than lateral rectus underaction. Manifestations of strabismus and limitation of duction were variable and changed frequently during the follow-up period. The combined use of prednisone and pyridostigmine was found to be the predominant form of maintenance therapy, and ptosis was more responsive to drug therapy than limited ocular motility.

Conclusions: Children with ocular MG were found to have a high incidence of ptosis (96%) and exotropia and vertical hyperdeviation. Limitation on adduction was less common than that on abduction. First reported incidence of amblyopia (21%) and a relative nonresponsiveness of the limitation of eye movement to treatment were also noted.

Citing Articles

Demographics and ocular findings in children with myasthenia.

Arruti N, Munot P, Bowman R Eye (Lond). 2022; 37(4):700-704.

PMID: 35338356 PMC: 9998382. DOI: 10.1038/s41433-022-02030-5.


The Epidemiology and Phenotypes of Ocular Manifestations in Childhood and Juvenile Myasthenia Gravis: A Review.

Heckmann J, Europa T, Soni A, Nel M Front Neurol. 2022; 13:834212.

PMID: 35280301 PMC: 8904732. DOI: 10.3389/fneur.2022.834212.


Ophthalmologic manifestations in myasthenia gravis: presentation and prognosis.

Akan O, Baysal-Kirac L Acta Neurol Belg. 2021; 121(5):1131-1140.

PMID: 33439450 DOI: 10.1007/s13760-020-01556-3.


Initial Treatment Response in Ocular Myasthenia Gravis: A Comparison Between Low and Moderate Doses of Prednisolone.

Threetong T, Poonyathalang A, Preechawat P, Jindahra P, Padungkiatsagul T, Vanikieti K Clin Ophthalmol. 2020; 14:2051-2056.

PMID: 32801613 PMC: 7383101. DOI: 10.2147/OPTH.S261259.


Pediatric Ocular Myasthenia Gravis.

Fisher K, Shah V Curr Treat Options Neurol. 2019; 21(10):46.

PMID: 31559492 DOI: 10.1007/s11940-019-0593-y.